Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stella M. Davies, MBBS, PhD
Children's Hospital Medical Center, Cincinnati
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S and Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Aflac Cancer Center and Blood Disorders Service of Children'S Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, United States
- Riley'S Children Cancer Center at Riley Hospital for Children
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Unmc Eppley Cancer Center at the University of Nebraska Medical Center
Omaha, Nebraska, United States
- Ccop - Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
New York, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Dayton Children'S - Dayton
Dayton, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 30 Jun 2016
- Completion
- 31 Mar 2020
- Last update posted
- 16 Apr 2020
- Registered enrollment
- 158
- Registry id
- NCT00553202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.